In few days, the I3LUNG consortium comes together for our Annual Meeting, a key milestone as we enter the final sprint of our project.

Over the past years, our partners have worked collaboratively to advance AI-driven decision support for lung cancer screening and care. Now, we are ready to focus our energy on the last phase: consolidating results, strengthening our impact, and maximising the project’s legacy.

One more sprint, let’s make it count!

Go team! 💙🫁🇪🇺💪🏻

The post Countdown for our 5th Annual Meeting is ON appeared first on I³LUNG.

This was an excellent opportunity to illustrate the different advancements the project is making to strengthen individualized treatment decision-making, from AI-supported diagnosis to decision support solutions for clinicians, in front of a packed room of more than 200 engaged professionals.

AI is increasingly present in oncology workflows and we’re happy to interface with fellow experts and this many high-level initiatives. 🙌🏻🤖👨🏻‍⚕️👩🏼‍⚕️

The post Treatment prediction: from Predictive to Generative AI Tools appeared first on I³LUNG.

We had an engaged group of 8 participants, and while we couldn’t cover everything planned, the discussion naturally focused on:

🇪🇺 Patient consent, GDPR, and medical research
🇪🇺 When the AI Act and MDR apply to AI-based tools in healthcare
🇪🇺 International data transfers under GDPR

What stood out most was the strong interest in the real-world application of these regulations in medical AI research.

Many thanks to the participants that showed up and to our #I3LUNG team for the work 💪🏻🫁💙

The post Workshop: navigating the EU regulatory framework for international AI-driven medical research appeared first on I³LUNG.

🗣️ Workshop title: Navigating the EU Regulatory Maze to Conduct International Medical Research Developing AI
📍 Location: Maison de la Poste
🕒 Date & time: Friday, 22 May | 14:15–15:30 CET
🌍 Conference: CPDP 2026 – Computers, Privacy and Data Protection

The session will explore the regulatory and data protection challenges surrounding international AI-driven medical research across Europe.

➡️ More information here:
https://lnkd.in/d2FCHYMA

➡️ Check video on Linkedin

The post Workshop at Computers, Privacy and Data Protection Conference (CPDP) appeared first on I³LUNG.

The #I3LUNG partners are involved in these sessions:

➡️ Bias at the source: understanging and mitigating data imbalances in NSCLC and immunotherapy (Vanja Mišković)
➡️ AI-driven pathology in clinical practice: head and neck and other cancrs example use case (Alexander Pearson)
➡️ LLMs for target and drug discovery: a personalized therapy for every single patient (Matteo Sacco)
➡️ Transforming oncology patient journey with agentic AI (Francesco Trovò)

Of course Arsela Prelaj as co-president of the conference.
And Helena Linardou and Alessandra Pedrocchi as part of the scientific committee.

Find the program and more information here: https://lnkd.in/dReRmhz4

The post ESAC: First Annual Meeting (AI for oncology) appeared first on I³LUNG.

As cancer care shifts toward biomarker-driven, AI-supported treatment decisions, many existing NSCLC models still overlook diagnostic performance and misclassification, despite their critical impact on patient outcomes.

Based on a review of 237 published models, this work calls for a shift toward modelling treatment strategies, linking decision rules, treatment assignment, and patient pathways over time.

It also highlights the role of open-source platforms in improving transparency, validation, and collaboration in increasingly complex decision-making.

🔗 https://lnkd.in/dqUjSp7Z

#HealthEconomics #EuropeanFundedProject

The post 2026 Swedish Health Economics Conference (SHEA) appeared first on I³LUNG.

An achievement that recognizes the transformative potential (and initial successes) of #AI for cancer care and research!

What a meaningful milestone that inspires us to continue pushing innovation forward for patients, researchers, and the future of oncology and AI. 🤖💙

#GoTeamI3LUNG

The post We gained the first prize in the “Innovators Category” appeared first on I³LUNG.

🧠 Session: AI-based procedures to augment clinical trials
🕥 Time: 10:15 – 11:45

The session will feature leading experts in the field, including Dr. Arsela Prelaj (Milan, Italy), who will open the session with her lecture:
🎙️ 10:15 – 10:30 | AI for genomic precision medicine in clinical trials

Chaired by:
👩‍⚕️ Mihaela Aldea (Villejuif, France)
👨‍⚕️ Jakob Nikolas Kather (Dresden, Germany)

The post How is artificial intelligence reshaping the landscape of oncology clinical trials? appeared first on I³LUNG.

📍: Hanover Auditorium – Hall 7.2c
🕐: 14:00 – 15:30

We’re ready for another excellent congress ahead! 🫁🇪🇺

The post Kicking-off #ESMO25 at the International Congress Center MESSE in Berlin, Germany. appeared first on I³LUNG.

Artificial intelligence is revolutionizing how we design and conduct clinical trials in oncology. On November 6th, leading experts will gather in Rome for “AI in Clinical Trials”, organized by ESAC – European Interdisciplinary Society of AI for Cancer Research, to explore innovative trial designs, trustworthy AI implementation, and real-world data applications.

You can follow the event in person or online.

🔗 To register, click here

The post AI in Clinical Trials appeared first on I³LUNG.